On CNBC's “Mad Money Lightning Round,” Jim Cramer said Affirm Holdings Inc AFRM is a buy. “It's at $72, it's going to $100,” he noted.
On the earnings front, Affirm will announce its fourth quarter fiscal year results after the closing bell on Aug. 28.
When asked about Eli Lilly And Co LLY, he said, “Down here, I begin to think that we are too negative on it. But I am very upset with Lilly and the way they handled this, and I think they should come back on and talk to me.”
As per the recent news, Eli Lilly, on Aug. 7, released topline data from the Phase 3 ATTAIN-1 trial evaluating orforglipron, an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist.
“I don't want to be connected with Brazil,” Cramer said when asked about Banco Bradesco SA BBD. “It's had a big run. If you want an overseas bank, I think you should be in Santander.”
On May 28, Citigroup analyst Rafael Frade upgraded Bank Bradesco from Neutral to Buy.
Cramer said, “I think longer term, ServiceNow NOW has really good AI, and it would not be a stock that I would want to bet against. So, ServiceNow longer term I think is fine. Shorter term I think it's going to be under pressure.”
ServiceNow, on July 23, reported second-quarter revenue of approximately $3.22 billion, beating the consensus estimate of $3.12 billion, according to Benzinga Pro. The company reported second-quarter adjusted earnings of $4.09 per share, beating analyst estimates of $3.57 per share.
Price Action:
Read Next:
Image: Shutterstock
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。